Latest Breaking News On - Jefferies innovation in mental health summit - Page 2 : comparemela.com

- Seelos SLS-002 is currently being developed specifically to treat the symptoms of suicidality associated with major depressionNEW YORK, Aug. 30.

New yorkUnited statesSan franciscoRaj mehraMike moyerAnthony marcianoJavelin pharmaceuticals inc hospiraPrnewswire seelos therapeutics incLifesci advisorsSeelos therapeutics incExchange commissionJefferies innovation in mental health summitAgency for healthcare researchMental health summitNew emerging treatmentsNew york city